ACTRIMS Action Center
Explore the forefront of multiple sclerosis research with the ACTRIMS Action Center. Here you’ll find leading experts in the field share insights on the latest studies, innovative treatment approaches, and evolving patient management strategies that emerged from the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum.
1-15 of 21
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
NeuroFrontiersMultiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
Raphael Schneider, MD, PhD, FRCPC, CIP
Understanding Accelerated Biological Aging in Pediatric MS
NeuroFrontiersUnderstanding Accelerated Biological Aging in Pediatric MS
Jennifer Yang, MD
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
NeuroFrontiersAdvancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
Adil Harroud, MD
Dylan Hamitouche
Ryan Quigley
Evaluating Structured Interventions for Cognitive Support in MS
AudioAbstractsEvaluating Structured Interventions for Cognitive Support in MS
Hallie Blevins, PhD
Optimizing Vitamin D Supplementation in MS Care
NeuroFrontiersOptimizing Vitamin D Supplementation in MS Care
The Role of Neurofilament Light Chain in MS Management
NeuroFrontiersThe Role of Neurofilament Light Chain in MS Management
- advertisement
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
NeuroFrontiersEngineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
Christian Cordano, MD, PhD
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiersSafety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
Amber Salter, PhD
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiersMS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
Michael Kornberg, MD, PhD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiersUnderstanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Dalia Rotstein, MD, MPH
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiersEmerging Technologies in MS: Neuromodulation and Myelin Regeneration
Cristin Welle, PhD
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiersMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Amy Kuceyeski, PhD
- advertisement
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiersAdvancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiersExploring the Latest in MS Cognitive Rehabilitation Strategies
Nancy Chiaravalloti, PhD
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
NeuroFrontiersVisionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
Daniel Harrison, MD
